Status:
UNKNOWN
Treatment of Ocular Demodex Infestation With Topical Ivermectin Cream 1%
Lead Sponsor:
Helm Vision Group
Conditions:
The Focus of the Study is to Assess the Effectiveness of Topical Ivermectin on Eliminating Eyelash Sleeves
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
Patients with Demodex infestation of the eyelids will have the sleeves from both eyes cleaned off with microblepharoexfoliation. Afterwards, one eye will be randomly selected for treatment with topica...
Detailed Description
Informed Consent Form and Authorization to Use and Disclose Protected Health Information Sponsor / Study Title: Helm Vision Group / "Treatment of Ocular Demodex Infestation with Topical Ivermectin C...
Eligibility Criteria
Inclusion
- Voluntary participation of subjects with moderate to dense sleeves with no allergy to ivermectin and the ability to keep follow-up appointments.
- \-
Exclusion
- Patients under 18 years old and those allergic to ivermectin.
- \-
Key Trial Info
Start Date :
August 24 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05213585
Start Date
August 24 2021
End Date
December 31 2022
Last Update
January 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Helm Vision Group
Santa Clarita, California, United States, 91355